{"id":"https://openalex.org/W2061738696","doi":"https://doi.org/10.1111/dom.12230","title":"A prospective, claims\u2010based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs","display_name":"A prospective, claims\u2010based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-06","ids":{"openalex":"https://openalex.org/W2061738696","doi":"https://doi.org/10.1111/dom.12230","mag":"2061738696","pmid":"https://pubmed.ncbi.nlm.nih.gov/24199745","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4237552"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12230","doi":"https://doi.org/10.1111/dom.12230","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12230","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12230","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2061738696"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12230","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040851165","display_name":"Donnie P. Funch","orcid":"https://orcid.org/0000-0003-3462-2716","observed_orcids":["https://orcid.org/0000-0003-3462-2716"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"D. Funch","raw_affiliation_strings":["Optum, Epidemiology, Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum, Epidemiology, Waltham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008150093","display_name":"Helge Gydesen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"H. Gydesen","raw_affiliation_strings":["Epidemiology Novo Nordisk A/S S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology Novo Nordisk A/S S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017628699","display_name":"Karen Torn\u00f8e","orcid":"https://orcid.org/0000-0003-4364-0000","observed_orcids":["https://orcid.org/0000-0003-4364-0000"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"K. Torn\u00f8e","raw_affiliation_strings":["Medical & Science GLP\u20101, Novo Nordisk A/S S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical & Science GLP\u20101, Novo Nordisk A/S S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086346174","display_name":"Atheline Major\u2010Pedersen","orcid":"https://orcid.org/0000-0002-1755-630X","observed_orcids":["https://orcid.org/0000-0002-1755-630X"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"A. Major\u2010Pedersen","raw_affiliation_strings":["Global Safety Novo Nordisk A/S Bagsv\u00e6rd Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Safety Novo Nordisk A/S Bagsv\u00e6rd Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045255444","display_name":"K. Arnold Chan","orcid":"https://orcid.org/0000-0001-8161-1986","observed_orcids":["https://orcid.org/0000-0001-8161-1986"]},"institutions":[{"id":"https://openalex.org/I16733864","display_name":"National Taiwan University","ror":"https://ror.org/05bqach95","country_code":"TW","type":"education","lineage":["https://openalex.org/I16733864"]},{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"K. A. Chan","raw_affiliation_strings":["National Taiwan University College of Medicine, Graduate Institute of Oncology, Taipei, Taiwan","National Taiwan University Hospital, Department of Medical Research, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University College of Medicine, Graduate Institute of Oncology, Taipei, Taiwan","institution_ids":["https://openalex.org/I16733864"]},{"raw_affiliation_string":"National Taiwan University Hospital, Department of Medical Research, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5040851165"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":6.2598,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.97395833,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"16","issue":"3","first_page":"273","last_page":"275"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/acute-pancreatitis","display_name":"acute pancreatitis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":1.0},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7490000128746033},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9200000166893005},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8960000276565552},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8569999933242798},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9282812476158142},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.762580394744873},{"id":"https://openalex.org/C2775967933","wikidata":"https://www.wikidata.org/wiki/Q1527888","display_name":"Pancreatitis","level":2,"score":0.645165741443634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6119415163993835},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.49256545305252075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4180021286010742},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36023008823394775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33040517568588257},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3232497274875641},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19801464676856995},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.08468696475028992}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007344","descriptor_name":"Insurance Claim Reporting","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D007348","descriptor_name":"Insurance, Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.12230","doi":"https://doi.org/10.1111/dom.12230","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12230","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12230","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:24199745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24199745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:4237552","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4237552/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.793.3108","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.793.3108","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/eb/df/dom0016-0273.PMC4237552.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1111/dom.12230","doi":"https://doi.org/10.1111/dom.12230","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12230","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12230","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309070","display_name":"Brown University","ror":"https://ror.org/05gq02987"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2061738696.pdf","grobid_xml":"https://content.openalex.org/works/W2061738696.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1529223681","https://openalex.org/W2054925541","https://openalex.org/W2058683641","https://openalex.org/W2066987382","https://openalex.org/W2092014168","https://openalex.org/W2094195067","https://openalex.org/W2112981414","https://openalex.org/W2122696108","https://openalex.org/W2124876714","https://openalex.org/W2136259411","https://openalex.org/W2137982063","https://openalex.org/W2164535707","https://openalex.org/W2596357415"],"related_works":["https://openalex.org/W2925901874","https://openalex.org/W2113941930","https://openalex.org/W2098737080","https://openalex.org/W1976838333","https://openalex.org/W2111640589","https://openalex.org/W4414485074","https://openalex.org/W2149661916","https://openalex.org/W3034203622"],"abstract_inverted_index":{"AIM:":[0],"We":[1,62,142],"evaluated":[2],"the":[3],"relationship":[4],"between":[5],"liraglutide":[6,102,127,153],"and":[7,54,72],"acute":[8,86,99],"pancreatitis":[9,87,100],"or":[10,27,35,88,157],"pancreatic":[11,89,122],"cancer":[12,90,123],"in":[13,39],"an":[14],"ongoing":[15],"post-marketing":[16],"safety":[17],"assessment":[18],"programme.":[19],"METHODS:":[20],"Initiators":[21],"of":[22,31,59,77,83,148],"liraglutide,":[23],"exenatide,":[24],"metformin,":[25],"pioglitazone":[26],"groups":[28],"containing":[29],"initiators":[30],"dipeptidyl":[32],"peptidase-4":[33],"inhibitors":[34],"sulfonylureas":[36],"were":[37],"identified":[38],"a":[40,57],"US":[41],"commercial":[42],"health":[43],"insurance":[44,79],"claims":[45,80],"database":[46],"(1":[47],"February":[48],"2010":[49],"to":[50,155],"31":[51],"March":[52],"2013)":[53],"followed":[55],"for":[56,98,101,108,121,126,131],"median":[58],"15":[60],"months.":[61],"estimated":[63],"incidence":[64],"rates":[65],"(IR/100":[66],"000":[67],"person-years),":[68],"rate":[69],"ratio":[70],"(RR)":[71],"95%":[73,138],"confidence":[74],"intervals":[75],"(CI)":[76],"new":[78],"with":[81,106,129,152],"diagnoses":[82],"primary":[84],"inpatient":[85],"from":[91],"Poisson":[92],"regression":[93],"models.":[94],"RESULTS:":[95],"The":[96,119],"IR":[97,120],"was":[103,124],"187.5":[104],"compared":[105,128],"154.4":[107],"all":[109,132],"non-glucagon-like":[110],"peptide-1":[111],"(GLP-1)-based":[112],"therapies":[113,134],"(adjusted":[114,135],"RR":[115,136],"1.10;":[116],"CI":[117,139],"0.81-1.49).":[118],"19.9":[125],"33.0":[130],"non-GLP-1-based":[133],"0.65;":[137],"0.26-1.60).":[140],"CONCLUSION:":[141],"did":[143],"not":[144],"observe":[145],"excess":[146],"risk":[147],"either":[149],"outcome":[150],"associated":[151],"relative":[154],"individual":[156],"pooled":[158],"comparator":[159],"drugs.":[160]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2061738696","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
